Skip to main content

Diazepam News

FDA Approves Libervant (diazepam) Buccal Film for the Treatment of Seizure Clusters in Pediatric Patients Ages 2-5 Years

WARREN, N.J., April 29, 2024 (GLOBE NEWSWIRE) – Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improve...

Could Ativan Pose Harm to People Battling Pancreatic Cancer?

THURSDAY, Aug. 17, 2023 – Sometimes patients with pancreatic cancer are prescribed the benzodiazepine lorazepam (Ativan) for anxiety, but that may be harming their health. A new study found this...

Study Looks at Links Between Anxiety Disorders, Benzodiazepines, Dementia

MONDAY, Aug. 14, 2023 – Benzodiazepines and anxiety disorders are associated with dementia risk, but for patients with anxiety disorders, no additional risk is seen with benzodiazepine use,...

EMS Crews May Not Always Follow Guidelines When Dosing Kids: Study

MONDAY, July 10, 2023 – Less than half of all children treated by emergency medical services receive the right amount of medication during out-of-hospital emergencies, a new study found. In some...

Variation Seen in Dosing of Meds at Prehospital Pediatric Encounters

MONDAY, July 10, 2023 – For pediatric patients in the prehospital setting, weight-based dosing often varies from national guidelines, according to a study published online July 10 in Pediatrics....

FDA Medwatch Alert: Drug Safety Communication: Benzodiazepine Drug Class - Boxed Warning Updated to Improve Safe Use

ISSUE: The FDA is requiring the Boxed Warning, FDA’s most prominent warning, be updated by adding other information to the prescribing information for all benzodiazepine medicines. This information w...

FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment

SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, s...

FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death

ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...

FDA Medwatch Alert: Meridian Medical Technologies Auto-Injectors: Extension of Expiration Dates

including Auto-Injectors for Atropen (atropine) DuoDote (atropine/pralidoxime chloride) morphine sulfate pralidoxime chloride diazepam   [Posted 11/22/2013] ISSUE: FDA is aware of a disruption in ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Anxiety, Back Pain, Alcohol Withdrawal, Borderline Personality Disorder, Seizures, Night Terrors, Temporomandibular Joint Disorder, Seizure Prevention, Seizure Prophylaxis, Light Sedation, Muscle Spasm, Epilepsy

Related drug support groups

Valium

Diazepam patient information at Drugs.com